110 related articles for article (PubMed ID: 11720448)
1. Drug-induced alterations in tumour perfusion yield increases in tumour cell radiosensitivity.
Bennewith KL; Durand RE
Br J Cancer; 2001 Nov; 85(10):1577-84. PubMed ID: 11720448
[TBL] [Abstract][Full Text] [Related]
2. Transiently hypoxic tumour cell turnover and radiation sensitivity in human tumour xenografts.
Wadsworth BJ; Lee CM; Bennewith KL
Br J Cancer; 2022 Jun; 126(11):1616-1626. PubMed ID: 35031765
[TBL] [Abstract][Full Text] [Related]
3. Pentoxifylline: its pharmacokinetics and ability to improve tumour perfusion and radiosensitivity in mice.
Honess DJ; Dennis IF; Bleehen NM
Radiother Oncol; 1993 Sep; 28(3):208-18. PubMed ID: 8255998
[TBL] [Abstract][Full Text] [Related]
4. Effects of mitomycin C on the oxygenation and radiosensitivity of murine and human tumours in mice.
Durand RE; LePard NE
Radiother Oncol; 2000 Aug; 56(2):245-52. PubMed ID: 10927145
[TBL] [Abstract][Full Text] [Related]
5. Modification of tumour response by calcium antagonists in the SCVII/St tumour implanted at two different sites.
Wood PJ; Hirst DG
Int J Radiat Biol; 1989 Sep; 56(3):355-67. PubMed ID: 2570820
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II type 1 receptor blocker telmisartan inhibits the development of transient hypoxia and improves tumour response to radiation.
Wadsworth BJ; Cederberg RA; Lee CM; Firmino NS; Franks SE; Pan J; Colpo N; Lin KS; Benard F; Bennewith KL
Cancer Lett; 2020 Nov; 493():31-40. PubMed ID: 32763272
[TBL] [Abstract][Full Text] [Related]
7. Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control.
Strunz AM; Peschke P; Waldeck W; Ehemann V; Kissel M; Debus J
Int J Radiat Biol; 2002 Aug; 78(8):721-32. PubMed ID: 12194756
[TBL] [Abstract][Full Text] [Related]
8. Effect of pentoxifylline on radiation-induced G2-phase delay and radiosensitivity of human colon and cervical cancer cells.
Li YX; Weber-Johnson K; Sun LQ; Paschoud N; Mirimanoff RO; Coucke PA
Radiat Res; 1998 Apr; 149(4):338-42. PubMed ID: 9525497
[TBL] [Abstract][Full Text] [Related]
9. Perfusion-Limited Hypoxia Determines the Outcome of Radiation Therapy of Hypoxic Tumours.
Schiavo F; Toma-Dasu I; Lindblom EK
Adv Exp Med Biol; 2022; 1395():249-254. PubMed ID: 36527645
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline increases RIF-1 tumour pO2 in a manner compatible with its ability to increase relative tumour perfusion.
Honess DJ; Andrews MS; Ward R; Bleehen NM
Acta Oncol; 1995; 34(3):385-9. PubMed ID: 7779427
[TBL] [Abstract][Full Text] [Related]
11. Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia.
Olive PL; Durand RE; Raleigh JA; Luo C; Aquino-Parsons C
Br J Cancer; 2000 Dec; 83(11):1525-31. PubMed ID: 11076663
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of beneficial effect of pentoxifylline on persistent forms of arterial hypertension.
Mchedlishvili G; Tsinamdzvrihvili B; Momtselidze N; Beritashvili N
Clin Hemorheol Microcirc; 1998 Jul; 18(4):285-90. PubMed ID: 9741669
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment number of clonogenic cells and their radiosensitivity are major determinants of local tumour control after fractionated irradiation.
Yaromina A; Krause M; Thames H; Rosner A; Krause M; Hessel F; Grenman R; Zips D; Baumann M
Radiother Oncol; 2007 Jun; 83(3):304-10. PubMed ID: 17517444
[TBL] [Abstract][Full Text] [Related]
14. Elucidating the role of transiently hypoxic tumour cells on radiation resistance.
Higgins GS; Hammond EM
Br J Cancer; 2022 Apr; 126(7):971-972. PubMed ID: 35197582
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of the effects of mild systemic heating on human head and neck tumour xenografts: Analysis of tumour perfusion, interstitial fluid pressure, hypoxia and efficacy of radiation therapy.
Winslow TB; Eranki A; Ullas S; Singh AK; Repasky EA; Sen A
Int J Hyperthermia; 2015; 31(6):693-701. PubMed ID: 25986432
[TBL] [Abstract][Full Text] [Related]
16. Accounting for Two Forms of Hypoxia for Predicting Tumour Control Probability in Radiotherapy: An In Silico Study.
Lindblom E; Toma-Dasu I; Dasu A
Adv Exp Med Biol; 2018; 1072():183-187. PubMed ID: 30178343
[TBL] [Abstract][Full Text] [Related]
17. Quantifying transient hypoxia in human tumor xenografts by flow cytometry.
Bennewith KL; Durand RE
Cancer Res; 2004 Sep; 64(17):6183-9. PubMed ID: 15342403
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-12 has no effect on vascular density, perfusion, hypoxia and proliferation of an implanted human squamous cell carcinoma xenograft tumour despite up-regulation of ICAM-1.
van Herpen CM; Bussink J; van der Kogel AJ; Peeters WJ; van der Voort R; van Schijndel A; de Wilde PC; Adema GJ; de Mulder PH
Anticancer Res; 2005; 25(2A):1015-21. PubMed ID: 15868941
[TBL] [Abstract][Full Text] [Related]
19. Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.
Myerson RJ; Singh AK; Bigott HM; Cha B; Engelbach JA; Kim J; Lamoreaux WT; Moros E; Novak P; Sharp TL; Straube W; Welch MJ; Xu M
Int J Hyperthermia; 2006 Mar; 22(2):93-115. PubMed ID: 16754595
[TBL] [Abstract][Full Text] [Related]
20. Identification of nonproliferating but viable hypoxic tumor cells in vivo.
Durand RE; Raleigh JA
Cancer Res; 1998 Aug; 58(16):3547-50. PubMed ID: 9721858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
